CONSOLIDATED STATEMENTS OF EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)	Treasury Stock
Balance, beginning of the period (in shares) at Mar. 31, 2020		143,938,753
Balance, beginning of the period at Mar. 31, 2020	$ 1,087,512	$ 14,394	$ 1,496,565	$ 1,545,094	$ 5,745	$ (1,974,286)
Treasury stock, beginning balance (in shares) at Mar. 31, 2020						(78,081,314)
Increase (Decrease) in Stockholders' Equity
Employee stock awards, benefit plans and other issuances (in shares)		583,476				(182,730)
Employee stock awards, benefit plans and other issuances	(1,182)	$ 58	8,680			$ (9,920)
Non-cash stock-based compensation (in shares)		21,736
Non-cash stock-based compensation	84,396	$ 2	84,394
Restricted stock units vested (in shares)		2,186,763
Restricted stock units vested	0	$ 219	(219)
Liability-classified restricted stock units vested (in shares)		1,084,237
Liability-classified restricted stock units vested	40,760	$ 108	40,652
Acquisition of treasury stock (in shares)						(1,321,666)
Acquisition of treasury stock	(42,312)					$ (42,312)
Comprehensive income (loss):
Foreign currency translation	1,777				1,777
Net loss	(90,268)			(90,268)
Treasury stock, ending balance (in shares) at Mar. 31, 2021						(79,585,710)
Balance, end of the period (in shares) at Mar. 31, 2021		147,814,965
Balance, end of the period at Mar. 31, 2021	1,080,683	$ 14,781	1,630,072	1,454,826	7,522	$ (2,026,518)
Increase (Decrease) in Stockholders' Equity
Employee stock awards, benefit plans and other issuances (in shares)		254,069				(290,675)
Employee stock awards, benefit plans and other issuances	(8,360)	$ 26	6,240			$ (14,626)
Non-cash stock-based compensation (in shares)		52,459
Non-cash stock-based compensation	71,180	$ 5	71,175
Restricted stock units vested (in shares)		1,131,489
Restricted stock units vested	0	$ 113	(113)
Liability-classified restricted stock units vested (in shares)		547,343
Liability-classified restricted stock units vested	13,803	$ 55	13,748
Acquisition-related restricted stock award (in shares)		40,600
Acquisition-related restricted stock award	0	$ 4	(4)
Acquisition of treasury stock (in shares)						(1,329,211)
Acquisition of treasury stock	(58,621)					$ (58,621)
Comprehensive income (loss):
Foreign currency translation	(1,792)				(1,792)
Net loss	$ (33,833)			(33,833)
Treasury stock, ending balance (in shares) at Mar. 31, 2022	81,200,000					(81,205,596)
Balance, end of the period (in shares) at Mar. 31, 2022		149,840,925
Balance, end of the period at Mar. 31, 2022	$ 1,063,060	$ 14,984	1,721,118	1,420,993	5,730	$ (2,099,765)
Increase (Decrease) in Stockholders' Equity
Employee stock awards, benefit plans and other issuances (in shares)		399,146				(101,011)
Employee stock awards, benefit plans and other issuances	3,987	$ 40	6,219			$ (2,272)
Non-cash stock-based compensation (in shares)		47,093
Non-cash stock-based compensation	117,351	$ 5	117,346
Restricted stock units vested (in shares)		3,253,815
Restricted stock units vested	0	$ 325	(325)
Liability-classified restricted stock units vested (in shares)		446,805
Liability-classified restricted stock units vested	11,603	$ 45	11,558
Acquisition of treasury stock (in shares)						(6,066,230)
Acquisition of treasury stock	(149,997)					$ (149,997)
Comprehensive income (loss):
Foreign currency translation	(1,226)				(1,226)
Net loss	$ (118,702)			(118,702)
Treasury stock, ending balance (in shares) at Mar. 31, 2023	87,400,000					(87,372,837)
Balance, end of the period (in shares) at Mar. 31, 2023		153,987,784
Balance, end of the period at Mar. 31, 2023	$ 926,076	$ 15,399	$ 1,855,916	$ 1,302,291	$ 4,504	$ (2,252,034)